Long‐term follow‐up of anti‐HBe‐positive chronic active hepatitis B

Twenty‐eight patients with chronic active hepatitis without cirrhosis who were positive for hepatitis B surface antigen and antibody to hepatitis B e antigen were followed for 1 to 15 years (mean 6.6 years) and underwent follow‐up biopsy. At presentation, 12 of the 28 patients (43%) had hepatitis B virus DNA in serum, 10 (36%) had serologic evidence of hepatitis delta virus infection and 6 (21%) had no serologic markers of either hepatitis B virus replication or hepatitis delta virus infection. During follow‐up, 15 (54%) patients developed active cirrhosis, including eight patients with hepatitis delta virus infection and five with hepatitis B virus DNA in serum. In seven (47%) of the 15 patients, cirrhosis developed within the first 2 years; all seven patients had bridging necrosis in the first liver biopsy, and five of these were infected with hepatitis delta virus. The remaining 13 (46%) patients did not develop cirrhosis during follow‐up and showed either unchanged features of chronic active hepatitis (seven cases) or histologic improvement to chronic persistent hepatitis (five cases) or to normal liver (one case). In conclusion, the prognosis of anti‐HBe‐positive patients with chronic hepatitis B is poor, as 54% of the cases developed cirrhosis during a mean histologic follow‐up period of 4.5 years, mainly in association with hepatitis delta virus infection or continuing hepatitis B virus replication.

[1]  M. Rugge,et al.  Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti‐HBe in chronic hepatitis type B , 1986, Hepatology.

[2]  J. Hoofnagle,et al.  Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. , 1981, Annals of internal medicine.

[3]  H. Thomas,et al.  Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum , 1985, Hepatology.

[4]  Iversen Ll.  Neurotransmitters and CNS disease. Introduction. , 1982 .

[5]  D. Shafritz,et al.  Detection of Hepatitis B Virus DNA Directly in Human Serum by a Simplified Molecular Hybridization Test: Comparison to HBeAg/ Anti‐HBe Status in HBsAg Carriers , 2007, Hepatology.

[6]  F. Negro,et al.  Hepatitis B virus DNA (HBV-DNA) in anti-HBe positive sera. , 2008, Liver.

[7]  G. Fattovich,et al.  Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients. , 1986, The Journal of infectious diseases.

[8]  J. Gerin,et al.  Hepatitis B virus DNA in the sera of HBsAg carriers: A marker of active hepatitis B virus replication in the liver , 1981, Hepatology.

[9]  M. Rizzetto,et al.  Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. , 1983, Annals of internal medicine.

[10]  F. Callea,et al.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. , 1986, Gastroenterology.

[11]  G. Fattovich,et al.  Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. , 1987, The Journal of infectious diseases.

[12]  G. Kanel,et al.  Chronic delta infection and liver biopsy changes in chronic active hepatitis B. , 1984, Annals of internal medicine.

[13]  A. Lok,et al.  Clinical and histological features of delta infection in chronic hepatitis B virus carriers. , 1985, Journal of clinical pathology.

[14]  M. Rugge,et al.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection , 1980 .

[15]  A. Lok,et al.  Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. , 1984, Gut.

[16]  D. Shafritz,et al.  Analysis of Liver Disease, Nuclear HBcAg, Viral Replication, and Hepatitis B Virus DNA in Liver and Serum of HBcAg Vs. Anti‐HBe Positive Carriers of Hepatitis B Virus , 2007, Hepatology.